This is for the phase 3 trial. Both companies started their trials for younger kids but the first phase (1/2) was a smaller trial to determine the proper dose. Once the dose is decided they are both doing a full phase 3 trial with thousands of participants. The initial phase 1/2 dose trials are about to wrap up so they are lining up participants now for the phase 3
trial.
CHOP is working with Moderna on their kidcove trial. Based on the response we got it looks like they are about to ramp up the phase 3 trial.
The study is the first to include infants and toddlers
www.phillyvoice.com